Phase I study of IL-8 inhibitor AMY109 plus atezolizumab (atezo) in patients (pts) with advanced solid tumours

被引：0
|
作者：
Kuboki, Y. [1 ]
Kitano, S. [2 ]
Ikeda, M. [3 ]
Koyama, T. [4 ]
Mizugaki, H. [5 ,6 ]
Narikiyo, T. [7 ]
Yamaguchi, Y. [8 ]
Ishida, T. [9 ]
Takubo, R. [10 ]
Ogami, C. [11 ]
Sekiya, M. [12 ]
Nakagawa, Y. [13 ]
Yamamoto, N. [14 ]
机构：
[1] Natl Canc Ctr Hosp East, Expt Therapeut & GI Oncol Dept, Kashiwa, Chiba, Japan
[2] Canc Inst Hosp JFCR, Canc Immunotherapy Dev Dept, Koto Ku, Tokyo, Japan
[3] Natl Canc Ctr Hosp East, Hepatobiliary & Pancreat Oncol Dept, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr, Expt Therapeut, Res Inst, Tsukiji Campus,Chuo Ku, Tokyo, Japan
[5] Hokkaido Canc Ctr, Japanese Fdn Canc Res, Canc Inst Hosp, Dept Adv Med Dev, Tokyo, Japan
[6] Canc Inst Hosp JFCR, Tokyo, Japan
[7] Chugai Clin Res Ctr Co Ltd, Clin Study Management Dept, Tokyo, Japan
[8] Chugai Pharmaceut Co Ltd, Early Clin Dev Dept, Fukuoka, Japan
[9] Chugai Pharmaceut Co Ltd, Pharmaceut Sci Dept, Fukuoka, Japan
[10] Chugai Pharmaceut CO LtD, Pharmaceut Sci Dept, Fukuoka, Japan
[11] Chugai Pharmaceut Co Ltd, Pharmaceut Sci Dept, Fukuoka, Japan
[12] Chugai Pharmaceut Co Ltd, Safety Sci Dept, Fukuoka, Japan
[13] Chugai Pharmaceut Co Ltd, Biometr Dept, Chuo Ku, Tokyo, Japan
[14] NCCH Natl Canc Ctr Hosp, Dev Therapeut Dept, Tsukiji Campus,Chuo Ku, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2179
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1040P
引用
收藏
页码：S631 / S632
页数：2
相关论文
共 50 条
  • [41] Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer
    Bendell, J.
    O'Reilly, E. M.
    Middleton, M. R.
    Chau, I.
    Hochster, H.
    Fielding, A.
    Burke, W.
    Burris, H., III
    ANNALS OF ONCOLOGY, 2015, 26 (04) : 804 - 811
  • [42] Phase Ib, open-label, dose-escalation study of M9241 (NHS-IL12) plus avelumab in patients (pts) with advanced solid tumours
    Strauss, J.
    Vugmeyster, Y.
    Sznol, M.
    Pachynski, R. K.
    Trang, K.
    Chennoufi, S.
    Gulley, J. L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
    Sweeney, Christopher J.
    Chiorean, E. Gabriela
    Verschraegen, Claire F.
    Lee, Fa Chyi
    Jones, Suzanne
    Royce, Melanie
    Tye, Lesley
    Liau, Katherine F.
    Bello, Akintunde
    Chao, Richard
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4513 - 4520
  • [44] A phase I study of the heparanase inhibitor PI-88 given subcutaneously (sq) in patients (pts) with advanced solid malignancies
    Holden, S
    Basche, M
    O'Bryant, C
    Morrow, M
    Grolnic, S
    Persky, M
    Deem, C
    Roberts, K
    Ribbons, K
    Eckhardt, S
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S74 - S75
  • [45] A phase I study of bortezomib plus irinotecan in patients with advanced solid tumors
    Ryan, David R.
    O'Neil, Bell H.
    Supko, Jeffrey G.
    Lima, Carlo M. Rocha
    Dees, E. Claire
    Appleman, Leonard J.
    Clark, Jeffrey
    Fidias, Phinos
    Orlowski, Robert Z.
    Kashala, Oscar
    Eder, Joseph R.
    Cusack, James C., Jr.
    CANCER, 2006, 107 (11) : 2688 - 2697
  • [46] A phase I dose escalation study of docetaxel (TXT) with Ienograstim support in patients (pts) with solid tumours
    Mitchell, PLR
    Basser, R
    Gibbs, P
    Ng, S
    Underhill, C
    Chipman, M
    Gargano, J
    Soulas, F
    Appia, F
    Green, M
    ANNALS OF ONCOLOGY, 1998, 9 : 130 - 130
  • [47] Phase I study of an oral isotype-selective histone deacetylase (HDAC) inhibitor in patients (pts) with advanced solid tumors
    Siu, L. L.
    Carducci, M.
    Chen, E. X.
    Maclean, M.
    Pili, R.
    King, S.
    Patterson, T.
    Li, Z.
    Kalita, A.
    Reid, G. K.
    EJC SUPPLEMENTS, 2006, 4 (12): : 94 - 95
  • [48] Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours
    G Del Conte
    C Sessa
    R von Moos
    L Viganò
    T Digena
    A Locatelli
    E Gallerani
    A Fasolo
    A Tessari
    R Cathomas
    L Gianni
    British Journal of Cancer, 2014, 111 : 651 - 659
  • [49] A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
    Pronk, LC
    Vasey, P
    Sparreboom, A
    Reigner, B
    Planting, AST
    Gordon, RJ
    Osterwalder, B
    Verweij, J
    Twelves, C
    BRITISH JOURNAL OF CANCER, 2000, 83 (01) : 22 - 29
  • [50] Weekly administration of bendamustine:: A phase I study in patients with advanced progressive solid tumours
    Schöffski, P
    Seeland, G
    Engel, H
    Grünwald, V
    Paul, H
    Merkle, K
    Kowalski, R
    Ganser, A
    ANNALS OF ONCOLOGY, 2000, 11 (06) : 729 - 734
12345